These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 20668290)

  • 21. Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion.
    Lepore G; Bonfanti R; Bozzetto L; Di Blasi V; Girelli A; Grassi G; Iafusco D; Laviola L; Rabbone I; Schiaffini R; Bruttomesso D;
    Nutr Metab Cardiovasc Dis; 2018 Apr; 28(4):335-342. PubMed ID: 29428572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High prevalence in Malawi of sight-threatening retinopathy and visual impairment caused by diabetes: identification of population-specific targets for intervention.
    Burgess PI; Allain TJ; García-Fiñana M; Beare NA; Msukwa G; Harding SP
    Diabet Med; 2014 Dec; 31(12):1643-50. PubMed ID: 24823871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intensified glucose control in type 2 diabetes--whose agenda?
    Yudkin JS; Richter B; Gale EA
    Lancet; 2011 Apr; 377(9773):1220-2. PubMed ID: 21093903
    [No Abstract]   [Full Text] [Related]  

  • 24. [Self monitoring of blood glucose: tool for successful diabetes therapy].
    Hummel M
    MMW Fortschr Med; 2012 Nov; 154(20):65-8. PubMed ID: 23234124
    [No Abstract]   [Full Text] [Related]  

  • 25. Improvements in diabetes treatment.
    Zimmerman BR
    Minn Med; 1995 Apr; 78(4):46-8. PubMed ID: 7760785
    [No Abstract]   [Full Text] [Related]  

  • 26. 6(th) Annual Symposium on Self-Monitoring of Blood Glucose (SMBG) applications and beyond, April 25-27, 2013, Riga, Latvia.
    Alzaid A; Schlaeger C; Hinzmann R
    Diabetes Technol Ther; 2013 Dec; 15(12):1033-52. PubMed ID: 24074038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HbA(1c) targets for type 2 diabetes: how many, …how far!
    Giugliano D; Ceriello A; Esposito K
    Diabetes Res Clin Pract; 2012 Jun; 96(3):414-5. PubMed ID: 21963106
    [No Abstract]   [Full Text] [Related]  

  • 28. Macular function in prediabetic and diabetic Omani adults: a microperimetric evaluation.
    Al Shafaee M; Shenoy R; Bialasiewicz AA; Ganguly SS; Bhargava K
    Eur J Ophthalmol; 2011; 21(6):771-6. PubMed ID: 21319136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retinopathy and vision loss in insulin-dependent diabetes in Europe. The EURODIAB IDDM Complications Study.
    Sjølie AK; Stephenson J; Aldington S; Kohner E; Janka H; Stevens L; Fuller J
    Ophthalmology; 1997 Feb; 104(2):252-60. PubMed ID: 9052629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study.
    Rosenstock J; Fonseca V; McGill JB; Riddle M; Hallé JP; Hramiak I; Johnston P; Davis M
    Diabetologia; 2009 Sep; 52(9):1778-88. PubMed ID: 19526210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Observations on the decay of glycated hemoglobin HbA1c in diabetic patients.
    Rech ME
    Exp Clin Endocrinol Diabetes; 1996; 104(2):102-5. PubMed ID: 8740932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Results of the treatment of diffuse diabetic macular edema by laser coagulation of the scatter grid type. Preliminary report].
    Nawrocka Z; Nawrocki J; Swietliczko I
    Klin Oczna; 1991 Sep; 93(9):259-61. PubMed ID: 1816460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hypoglycemia: danger to life of diabetic patients. Higher price for blood sugar adjustment].
    Füessl HS
    MMW Fortschr Med; 2005 Aug; 147(31-32):4-6, 8. PubMed ID: 16128187
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical aspects of Insulin Lispro (LY275585)].
    Kuzuya T
    Nihon Rinsho; 1997 Nov; 55 Suppl():298-305. PubMed ID: 9434484
    [No Abstract]   [Full Text] [Related]  

  • 35. Inferences and implications. Do results from the Diabetes Control and Complications Trial apply in NIDDM?
    Nathan DM
    Diabetes Care; 1995 Feb; 18(2):251-7. PubMed ID: 7729307
    [No Abstract]   [Full Text] [Related]  

  • 36. [Continuing care of patients with cardiovascular risk in general practice: diabetic patients and their care].
    Ilyés I; Jancsó Z; Kovács E; Márton H; Simay A
    Orv Hetil; 2005 Dec; 146(51):2581-8. PubMed ID: 16468612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of diabetic retinopathy and diabetic macular edema in a primary care-based teleophthalmology program for American Indians and Alaskan Natives.
    Bursell SE; Fonda SJ; Lewis DG; Horton MB
    PLoS One; 2018; 13(6):e0198551. PubMed ID: 29924846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The economic burden of diabetes and the benefits of improved glycemic control: the potential role of a continuous glucose monitoring system.
    Skyler JS
    Diabetes Technol Ther; 2000; 2 Suppl 1():S7-12. PubMed ID: 11469636
    [No Abstract]   [Full Text] [Related]  

  • 39. Should the target A1C level be less than 7 percent? Yes: This should be the target for most patients.
    Peterson K
    Am Fam Physician; 2012 Dec; 86(12):1-2. PubMed ID: 23316992
    [No Abstract]   [Full Text] [Related]  

  • 40. Prevalence of diabetic retinopathy in relation to age at onset of the diabetes, treatment, duration and glycemic control.
    Henricsson M; Nilsson A; Groop L; Heijl A; Janzon L
    Acta Ophthalmol Scand; 1996 Dec; 74(6):523-7. PubMed ID: 9017034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.